Thrombosis
Feature
A high-risk medical device didn’t meet federal standards. The government paid millions for more
For years after federal inspectors found serious problems with the HeartWare heart pump, agencies like the Department of Veterans Affairs and...
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
From the Journals
D-dimer thresholds rule out PE in meta-analysis
Data from a large review support use of D-dimer levels to diagnose PE without imaging.
Guidelines
ACC, AHA issue new coronary revascularization guideline
The clinical practice guideline calls for greater equity in patient care and tackles the timely issues of revascularization in stable ischemic...
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
From the Journals
Daily aspirin linked to increased risk of heart failure
Daily aspirin may need to be reconsidered in those at risk of heart failure, based on evidence of an association.
Conference Coverage
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a...
Latest News
Exercise reduces arm and shoulder problems after breast cancer surgery
Study provides the best quality evidence to date in support of early exercise for women at high risk of shoulder problems after breast cancer...
Conference Coverage
PRAGUE-17: LAA closure holds up against DOACs out to 4 years
Most outcomes remained unchanged, but follow-up imaging curtailed by the COVID-19 pandemic leaves an unfortunate gap with regard to late device-...
Conference Coverage
CABG safe 3 days after stopping ticagrelor: RAPID CABG
A new randomized trial showed similar rates of severe bleeding in patients going to surgery at 3 days and 6 days after stopping the antiplatelet...